Avalo Therapeutics AVTX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 12.71 | 92 | -31.23 | -31 | -24.34 | 125 |
| 2025Q2 | 4.99 | 105 | -18.28 | -21 | -15.67 | 127 |
| 2025Q1 | 8.01 | 123 | -10.29 | -13 | -9.09 | 139 |
| 2024Q4 | 7.43 | 133 | -45.86 | -35 | -28.36 | 151 |
| 2024Q3 | 9.50 | 21 | 23 | 22.28 | 98 | |
| 2024Q2 | 12.47 | -14 | 98 | 84.87 | 108 | |
| 2024Q1 | 21.75 | -113 | -121 | -167.62 | 124 | |
| 2023Q4 | 9.10 | 7 | -74.26 | -8 | -32.50 | 21 |
| 2023Q3 | 28.97 | 15 | -5 | -19.54 | 29 | |
| 2023Q2 | 85.25 | -7 | -8 | -27.10 | 24 | |
| 2023Q1 | 420.00 | -6 | -10 | -28.61 | 36 | |
| 2022Q4 | 1209.62 | -11 | -10 | -28.07 | 33 | |
| 2022Q3 | 796.80 | -2 | 3 | 9.28 | 37 | |
| 2022Q2 | 1440.00 | -6 | -13 | -27.60 | 32 | |
| 2022Q1 | 2087.14 | 6 | -149.88 | -22 | -31.03 | 62 |
| 2021Q4 | 4896.00 | 23 | -60.56 | -19 | -21.87 | 80 |
| 2021Q3 | 6278.40 | 40 | -56.21 | -17 | -21.82 | 95 |
| 2021Q2 | 22 | -62.49 | -17 | -26.85 | 64 | |
| 2021Q1 | 33 | -106.31 | -31 | -57.29 | 63 | |
| 2020Q4 | 25 | -49.56 | -16 | -30.39 | 44 |